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Abstract 
Background: There are two major theories describing the pathophysiology of migraines. Vascular theory explains 
that migraines resulted from vasodilation of meningeal vessels irritating the trigeminal nerves and causing pain. 
More recently, a neural theory of migraine has been proposed, which suggests that cortical hyperexcitability leads to 
cortical spreading depression (CSD) causing migraine-like symptoms. Chronic migraine requires prophylactic therapy. 
When oral agents fail, there are several intravenous agents that can be used. Understanding underlying causes of 
migraine pain would help to improve efficacy of migraine medications by changing their mechanism of action. Yet 
to date no study has been made to investigate the link between vascular changes in response to medications for 
migraine versus pain improvements. Functional near-infrared spectroscopy (NIRS) has been used as an inexpensive, 
rapid, non-invasive and safe technique to monitor cerebrovascular dynamics.
Method: In this study, a multi-distance near-infrared spectroscopy device has been used to investigate the cortical 
vascular reactivity of migraine patients in response to drug infusions and its possible correlation with changes in pain 
experienced. We used the NIRS on 41 chronic migraine patients receiving three medications: magnesium sulfate, 
valproate sodium, and dihydroergotamine (DHE). Patients rated their pain on a 1–10 numerical scale before and after 
the infusion.
Results: No significant differences were observed between the medication effects on vascular activity from near 
channels measuring skin vascularity. However, far channels—indicating cortical vascular activity—showed signifi-
cant differences in both oxyhemoglobin and total hemoglobin between medications. DHE is a vasoconstrictor and 
decreased cortical blood volume in our experiment. Magnesium sulfate has a short-lived vasodilatory effect and 
increased cortical blood volume in our experiment. Valproate sodium had no significant effect on blood volume. 
Nonetheless, all three reduced patients’ pain based on self-report and no significant link was observed between 
changes in cortical vascular reactivity and improvement in migraine pain as predicted by the vascular theory of 
migraine.
Conclusion: NIRS showed the potential to be a useful tool in the clinical setting for monitoring the vascular reactivity 
of individual patients to various migraine and headache medications.
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Cerebrovascular reactivity
© 2015 Pourshoghi et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/




*Correspondence:  arp76@drexel.edu 
1 School of Biomedical Engineering Science and Health, Drexel University, 
Room 131, 3508 Market St, Philadelphia, PA 19104, USA
Full list of author information is available at the end of the article
Page 2 of 8Pourshoghi et al. Eur J Med Res  (2015) 20:96 
Background
Neural and vascular theories are proposed as the main 
theories describing the pathophysiology of migraines 
[1]. Traditionally, it was thought that migraine resulted 
from vasoconstriction of cranial blood vessels leading to 
compensatory vasodilation. More recently, consensus has 
shifted toward a neural theory of migraine which consid-
ers the excessive neocortical cellular excitability as the 
main cause [2].
There are a number of studies reported in the literature 
that suggest possible different cortical vascular responses 
between healthy individuals and migraine patients in dif-
ferent scenarios. In several of these studies, NIRS has 
been used as a non-invasive method of measuring cer-
ebrovascular reactivity [3].
Akin et  al. have shown that amplitudes of deoxygen-
ated hemoglobin (Hb) and oxygenated hemoglobin 
(HbO2) signals acquired by NIRS are approximately two 
to five times higher in controls than migraine patients 
during four consecutive breath-holding tasks and con-
cluded their results as a confirmation of an impaired cer-
ebrovascular reactivity in the frontal cortex of migraine 
patients [4]. Shinoura et  al. have compared changes in 
total hemoglobin (THb) and regional oxygen saturation 
(rSO2) of the right and left frontal lobes in response to 
intracranial pressure changes during the interictal period 
of migraine. According to their findings, the head-down 
maneuver resulted in a significantly smaller increase in 
right-sided total hemoglobin in migraineurs compared 
to volunteers. Moreover, it resulted in a small decrease 
in right-sided rSO2 and a significantly greater decrease 
in left-sided rSO2 in migraineurs compared to volunteers 
[5]. In another study, both TCD (transcranial Doppler) 
and NIRS were used in migraineurs without aura versus 
healthy subjects in a breath-hold challenge. Strong dif-
ferences in the cerebral blood flow velocity (CBFV), a 
reduced increase of HbO2 and different hemoglobin bal-
ancing during breath-hold task have been reported for 
migraineurs. They have also concluded that migraineurs 
do not show marked vasodilation as a functional response 
to the CO2 increase [6]. The same parameters have been 
measured by Vernieri et al. using TCD and NIRS during 
carbon dioxide inhalation sessions of healthy subjects 
and migraineurs with aura (MA). Cerebral vasomotor 
reactivity (VMR), total hemoglobin content and percent 
oxygen increases were significantly greater on the pre-
dominant compared with the non-predominant migraine 
side. These findings suggest altered autoregulation in MA 
patients, possibly secondary to impaired cerebrovascular 
autonomic control [7].
In this study, we use NIRS to investigate the cerebro-
vascular effects of migraine medications and its possible 
correlation with patients’ pain improvement in real time.
In the remainder of this paper, we compare the vascu-
lar reactivity of 41 migraine patients receiving infusions 
of magnesium sulfate (21 patients), valproate sodium (12 
patients) and dihydroergotamine (6 patients). We also 
correlate our findings with the subjects’ pain score self-
reports. We aimed to investigate the utility of NIRS in 
comparing the analgesic efficacy of the above drugs based 
on patient self-reports compared with the measured cor-
tical vascular reactivity in the clinical setting.
Methods
NIRS basics
Light in the near-infrared range (600–900 nm) penetrates 
the tissue because water, the key overall absorber of light 
in human tissue, has a low NIR absorption coefficient. In 
this range, tissue behaves as a turbid medium and light 
is significantly scattered by oxyhemoglobin (HbO2) and 
deoxyhemoglobin (Hb) molecules. There are other absor-
bents such as melanin and lipids; however, their overall 
average concentrations along the total optical path are 
negligible.
As a result the NIR light detected in the Fig. 1 configu-
ration is absorbed and scattered mainly by the oxyhemo-
globin and deoxyhemoglobin molecules present in the 
blood stream. Any change in the concentrations of these 
molecules along the optical path of the detected photons 
will affect the detected signal. These changes can be the 
result of overall blood flow changes or local consumption 
of oxyhemoglobin due to neuronal activities.
Mathematical equations that govern this relation-
ship are known as the Modified Beer–Lambert law [8]. 
The modified Beer–Lambert law states that changes in 
the concentration of light absorbing components are 
proportional to changes in light attenuation, divided by 
mean optical pathlength and extinction coefficients of 
Fig. 1 Volume of tissue sampled by an NIRS measurement: the highly 
scattered photons are reflected back to the tissue’s surface, mostly 
within a banana-shaped optical pathway. As a result, a photodetector 
placed on the skin (on the same surface as the source) can measure 
the reflected light [19]
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the chromophores in the tissue. Optical pathlength is a 
measure of the average distance that light travels between 
the source and detector after several episodes of scatter-
ing and absorption.
The relative change in the concentration of Hb and 
HbO2 molecules can be calculated by the following 
equations:
Experiment protocol
We studied three commonly infused medications: mag-
nesium sulfate (MgSO4), valproate sodium, and dihydro-
ergotamine (DHE). DHE is a potent vasoconstrictor. It 
may constrict meningeal blood vessels causing sympto-
matic improvement consistent with the vascular theory. 
Magnesium sulfate has vasodilatory properties [9, 10] 
through its effects on serotonin, but its main effects are 
thought to be neural. Low levels of magnesium sulfate 
are associated with disinhibition of NMDA receptors. 
Magnesium-mediated calcium influx to NMDA neurons 
results in inhibition. Magnesium sulfate ions block cal-
cium influx and can prevent disinhibition. Low levels of 
magnesium lower the threshold for CSD (cortical spread-
ing depression).
Another group of drugs which are widely used in 
migraine are sodium channel antagonists. Among these 


















topiramate seem to be more effective in migraine, as 
reported in the majority of controlled studies [11]. Val-
proate sodium has no major vascular role; it works 
through increasing GABA levels and in so doing sup-
pressing CSD and migraines. Experimental evidence also 
shows that it suppresses neurogenic inflammation and 
attenuates nociceptive neurotransmission that leads to 
exacerbation of migraine.
These infusions are required when commonly used 
oral prophylactic drugs are not effective. Typically mag-
nesium sulfate was given first, valproate sodium next and 
DHE was given last.
Subjects
In this study, 41 patients (34 females) with an average age 
of 49.2 ± 9.5 years took part in a non-blinded trial using 
these medications; 21 subjects on magnesium sulfate, 12 
subjects on valproate sodium and 8 subjects on DHE. 
Migraine subjects met the International Headache Soci-
ety’s criteria for chronic migraine (ICHD-2) and were 
resistant to oral therapy. Patients rated their pain on a 
1–10 scale (NRS-11) before and at the end of the infu-
sion. The study was approved by the Drexel University 
Institutional Review Board (IRB) and informed consents 
and Ethics Committee approvals were obtained for all 
patients enrolled in the study, according to the Declara-
tion of Helsinki.
NIRS measurement
Throughout the duration of the experiment, subjects 
were monitored by the NIRS probes that were attached 
to their foreheads. The probe configuration is shown in 
Fig.  2. Each probe is made of an LED source and three 
detectors. One detector is 1  cm from the source (near 
Fig. 2 Configuration of NIRS probe: each probe has one LED source, one detector 1 cm from the source (near channel) and two detectors at 2.8 cm 
from the source (far channels)
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detector) and two detectors are 2.8 cm from the source 
(far detectors). The LED is a dual-wavelength LED 
(780 nm and 850 nm) manufactured by Epitex (L735/850-
40D32) and the detectors are OPT101 manufactured by 
Texas instruments [12, 13]. Using the modified Bear–
Lambert law (Eqs.  1, 2), the information about Hb and 
HbO2 is extracted from the raw intensity data.
After measuring the baseline for 2 min before infusion, 
we started the infusion and re-measured the cortical 
and superficial vascular activity with two NIRS probes. 
Probes were placed on the forehead of each subject—one 
on the right side of the forehead and one on the left side 
of the forehead and end of the probes were adjusted to 
align with the middle of the forehead—to cover position 
Fp1, Fp2 of the international 10–20 EEG system (Fig. 3).
During this time, we ensured that all external factors 
that could have significant effects on the NIRS measure-
ments were constant and controlled for; these include 
light, movement and temperature. Experimental protocol 
is shown in Fig. 4.
Results and discussion
Self‑reported measures
Patients rated their pain on a 1–10 scale (NRS-11) 
before and at the conclusion of the infusion. Figure 5 and 
Table 1 show initial pain and pain improvement after the 
infusion for each medication separately.
Reported initial pains were significantly different 
between medications (P  ≤  0.05) and were inherited 
from clinician’s policy of prescribing each drug. Aver-
age initial pain reported by patients for magnesium sul-
fate, valproate sodium and DHE was 4.4, 5.85 and 7.5, 
respectively. Magnesium sulfate was prescribed as an 
initial treatment and for patients with lower pain. Val-
proate sodium was used for patients whose pain was not 
improved by magnesium sulfate in previous sessions. If 
this was ineffective too, then DHE was considered. DHE 
was known to be more effective than magnesium sulfate 
and valproate sodium, and was prescribed for patients 
with higher pain. Based on self-reported pain scores, 
valproate sodium had a significant better pain improve-
ment over magnesium sulfate (P = 0.03). However, self-
reported pain score data do not show significant pain 
improvement between DHE and the other two drugs 
which could be the result of a small sample size.
NIRS data
Data were collected from six channels for each subject—
one near channel measuring vascular response of the skin 
and two far channels measuring vascular response from 
cortex and skin together on each side. Changes in the 
detected light intensity were converted to concentration 
changes of oxyhemoglobin (HbO2) and deoxyhemoglobin 
(Hb) in the blood through Beer–Lambert law (Eqs.  1, 
2). Figure 6 shows a sample of data reflecting changes in 
the total hemoglobin (THb) and oxyhemoglobin (HbO2) 
during the course of DHE infusion. Total hemoglobin is 
summation of oxyhemoglobin and deoxyhemoglobin and 
is a measure of total blood volume.
We examined the infusions’ effect on vascular reac-
tivity. The extracted feature from the signal was slope 
of oxyhemoglobin (HbO2), deoxyhemoglobin (Hb) and 
total hemoglobin (THb) data before and after the infu-
sion. After removing faulty signals, the remainder of the 
Fig. 3 ) NIRS probes placement: two NIRS probes are located on both 
sides of the forehead
Fig. 4 ) Experimental Protocol: NIRS data recorded for 2 mins before and 4 min after start of infusion. Whole infusion takes 15–30 min
Page 5 of 8Pourshoghi et al. Eur J Med Res  (2015) 20:96 
data included 18 magnesium sulfate, 10 valproate sodium 
and 6 DHE subjects. Due to small sample sizes and non-
normality of the data, Mann–Whitney U test (Wilcox 
test) was used to check if the difference in slope change 
between medications were significant.
No significant differences were observed between dif-
ferent medications on near channels which measure skin 
vascularity responses. This suggests that alternations 
in skin blood flow and autonomic response induced by 
drug infusion were not different between drugs. How-
ever, the analyses on far left channels showed significant 
differences in both HBO2 and THB between valproate 
sodium and magnesium sulfate and between magnesium 
sulfate and DHE (P < 0.001) reflecting differences in cor-
tical vascular reactivity among medications. In terms of 
slope changes in HbO2 and THb, we have the following 
order:
Magnesium sulfate > 0∼valproate sodium > DHE.
Positive slope change of THb for magnesium sulfate sug-
gests that local blood volume has increased due to mag-
nesium sulfate infusion and negative slope change for 
DHE shows decrease in blood volume by DHE infusion 
while for valproate sodium these changes are close to 
zero—no significant effect on blood volume.
Table  2 shows a summary of data and the changes in 
the HbO2, Hb and THb as measured by NIRS in an arbi-
trary unit for valproate sodium, magnesium sulfate and 
DHE as well as P values.
Cortical activity and skin response
In our experiments, near channels have penetration 
depth of 0.5 cm and measure alternations in skin vascular 
activity which are mostly caused by autonomic response. 
On the other hand, far channels capture up to 1.5 cm and 
measure cortical activities.
Our results on far channels showed that DHE 
decreased blood volume, magnesium sulfate increased 
blood volume and valproate sodium had no significant 
effect on the blood volume. The near channels, measur-
ing skin vascularity, showed no significant differences 
between the medications indicating that the results are 
not due to alteration in skin vascular activity.
Unilateral cortical response
Although data were collected from six channels on 
both sides of forehead, significant differences in corti-
cal activities between medications were only observed 
on the left side. Different left and right side cerebral 
reactivity in migraineurs has been reported before in 
literature as well. For instance, [13] reports a smaller 
increase in right-sided total hemoglobin (THb) and sig-
nificantly greater increase in left-sided total hemoglobin 
in migraineurs compared to volunteers. Moreover, some 
migraineurs have unilateral or side predominance pain 
which may also result in unilateral reactivity. A signifi-
cantly greater increase in total hemoglobin (THb) and 
percent oxygen on the predominant migraine side com-
pared with the non-predominant migraine side has been 
reported in [1].
However, the predominance side of pain (if existed at 
all) was not recorded in our data which makes it difficult 
to interpret.
Correlation between cortical response and self‑reported 
pain score
While these medications had significantly different 
effects on cortical vascular activities compared to each 
other, all three were effective in reducing the patients’ 
pain based on self-report. DHE, which is a well-known 
vasoconstriction, and MgSO4, which literature suggests 
Fig. 5 Self-reported pain scores by medication: subjects reported 
their pain based on a 1–10 numeric scale before and after the 
infusion. Changes between initial and final reported pain (Δ Pain) is 
considered as self-reported pain improvement
Table 1 Self-reported pain scores by  medication: aver-
age initial pain and  pain improvement have been shown 
for  each medication as  reported by  subjects before  and 
after infusion






 Mean 4.86 6.2 7.85




 Mean 1.81 3 2
 Standard  
deviation
1.33 1.70 2.24
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causes cortical vasodilation, showed a decrease and an 
increase in blood volume, respectively; during our trial, 
yet they were both effective in improving pain and val-
proate sodium with no significant vascular effect had 
the best self-reported pain improvement among the 
medications.
No significant link was observed between changes in 
cortical vascular reactivity and improvement in subjects’ 
self-reported pain scores.
Neuronal theory versus vascular theory
As explained briefly before there is no consensus about 
the underlying cause of migraine. It is possible that many 
factors may cause the class of headaches categorized as 
migraine. Neural and vascular theories are proposed as 
the main theories describing the pathophysiology of 
migraines [6]. Traditionally, it was thought that migraine 
resulted from vasoconstriction of cranial blood vessels 
leading to compensatory vasodilation. Although there 
is thought to be a decrease in cerebral blood flow in the 
acute phase that can cause the stereotypical aura, the pain 
in migraine is thought to be as a result of the increase in 
cerebral blood flow due to vasodilation of the middle 
meningeal artery. This increase in blood flow is depend-
ent upon trigeminal and parasympathetic activation.
In several studies, magnetic resonance angiography 
(MRA) has been employed to verify this theory. The 
method has been used to measure arterial changes before 
and after infusion of different vasoactive drugs and also 
before and during migraine headache attacks. However, 
the results are contradictory. The most recent study 
found intracranial but not extracranial arterial dilatation 
Fig. 6 Sample of recorded NIRS data during medication infusion (DHE for this subject) on a migraine patient: near channel (on left) measures 
oxyhemoglobin (HbO2) and total hemoglobin (THb) changes during the infusion on the skin while far channels (on right) measure both skin and 
cortical activities. Blue line infusion time
Table 2 Comparison of  infusion vascular reactivity between  medications on  both near  and far channels (mean 
and standard deviation values are only shown for far channels)
Far channel HbO2 Hb THb HbO2 Hb THb
Drug Valproate Mg Valproate Mg Valproate Mg DHE Mg DHE Mg DHE Mg
Mean −0.0003 0.004 0.003 0.01 −0.001 0.012 −0.001 0.004 0.013 0.02 −0.02 0.01
Standard deviation 0.001 0.005 0.009 0.027 0.002 0.012 0.001 0.005 0.083 0.027 0.03 0
P value (far) 0.008 0.22 0.0002 0.003 0.176 0.00001
P value (near) 0.36 0.29 0.23 0.62 0.87 0.82
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on the headache side relative to the non-headache side 
[14] while another earlier study reported that the mid-
dle cerebral artery (intracranial) and middle meningeal 
artery (extracranial) were both dilated on the pain side 
versus the non-pain side [15], and another MRA study of 
drug-induced migraine attacks reported no side-to-side 
changes at all [16]. The difference can be due to different 
study designs and drug effects [17].
In another study, the effect of several vasodilators on 
meningeal arteries was investigated to find a connection 
between the effect of a substance on a meningeal vessel and 
its ability to artificially induce migraine. No clear correlation 
was found between the efficacy of a substance as a menin-
geal artery vasodilator in human and the ability to artificially 
induce migraine or the mechanism of action [18].
More recently, consensus has shifted toward a neural 
theory of migraine which considers the excessive neo-
cortical cellular excitability as the main cause. According 
to this theory, neuronal hyperactivity will cause cortical 
spreading depression (CSD) and then CSD will trigger 
a migraine attack. CSD involves rapid depolarization of 
cortical neurons with cellular efflux of potassium, in turn 
triggering migraine [6].
Conclusion
Based on our results, no significant correlation was found 
between cortical vascular changes and pain improve-
ment. Both medications that have different vascular 
effect (Mg and DHE) have improved pain the same and 
valproate sodium which has no effect on vascularity had 
the best pain improvement. So our data suggest that 
vascular theory may not explain the pain improvement 
mechanism in migraine patients completely.
Our study had several limitations, which could be 
improved upon. We need a greater sample size of sub-
jects (particularly DHE) to attain more statistically signif-
icant results. Subjects who had valproate sodium infusion 
can be interpreted as control subjects because the mech-
anism of the drug is such that it does not affect blood 
flow. However, it would be better to have control subjects 
with saline infusion only to control the effect of infusion 
itself on the data. Part of the significance of these results 
lies in the fact that the data were collected in a typical 
community pain clinic and not in a quiet research labo-
ratory—speaking to the applicability of NIRS. Based on 
the work presented here, we believe that NIRS has the 
potential to be a useful tool in a clinical setting for assess-
ing the vascular effects of various medications for head-
ache and migraine. We believe that further technological 
improvement in NIRS hardware and signal analysis can 
make NIRS an even more useful tool for objective study 
and assessment of migraine. Furthermore, we hope that 
studies using NIRS can complement other measurements 
to facilitate the discussion about the underlying cause of 
the migraine headache.
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